Compare NPO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPO | INDV |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | N/A | N/A |
| Metric | NPO | INDV |
|---|---|---|
| Price | $225.48 | $36.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $243.33 | $32.50 |
| AVG Volume (30 Days) | 185.3K | ★ 3.5M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | ★ 58.40 | N/A |
| EPS | ★ 4.06 | 0.98 |
| Revenue | $1,106,300,000.00 | ★ $1,180,000,000.00 |
| Revenue This Year | $8.71 | $1.26 |
| Revenue Next Year | $9.74 | N/A |
| P/E Ratio | $55.26 | ★ $36.85 |
| Revenue Growth | ★ 6.44 | N/A |
| 52 Week Low | $133.50 | $7.62 |
| 52 Week High | $248.88 | $38.00 |
| Indicator | NPO | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 56.07 | 66.98 |
| Support Level | $204.25 | $35.21 |
| Resistance Level | $225.51 | $36.62 |
| Average True Range (ATR) | 7.08 | 0.88 |
| MACD | 0.57 | -0.17 |
| Stochastic Oscillator | 83.52 | 49.45 |
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.